SKI Market

Indian Indices

Sensex

82,269.78 -296.59
( -0.36%)

Global Indices

Nasdaq

48,928.31 -164.26
(-0.33%)

Dow Jones

6,963.16 -26.85
(-0.38%)

Hang Seng

53,392.10 16.50
(0.03%)

Nikkei 225

10,214.90 43.14
(0.42%)

Forex

USD-INR

91.92 0.08
(0.09%)

EUR-INR

109.97 0.03
(0.03%)

GBP-INR

126.94 0.27
(0.21%)

JPY-INR

0.60 0.00
(0.00%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Saptak Chem & Business Ltd

Industry : Trading

BSE Code

ISIN Demat

Book Value()

506906

INE467X01023

-21.7537669

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

4.93

EPS(TTM)

Face Value()

Div & Yield %

Back

Ajanta Pharma consolidated net profit rises 20.19% in the September 2025 quarter

Nov 03,2025

Net profit of Ajanta Pharma rose 20.19% to Rs 260.19 crore in the quarter ended September 2025 as against Rs 216.48 crore during the previous quarter ended September 2024. Sales rose 14.08% to Rs 1353.73 crore in the quarter ended September 2025 as against Rs 1186.64 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	1353.73	1186.64	14
OPM %	24.22	26.22	-
PBDT	383.78	324.63	18
PBT	340.81	290.24	17
NP	260.19	216.48	20

82,269.78 -296.59 ( -0.36%)

48,928.31 -164.26 (-0.33%)

6,963.16 -26.85 (-0.38%)

53,392.10 16.50 (0.03%)

10,214.90 43.14 (0.42%)

91.92 0.08 (0.09%)

109.97 0.03 (0.03%)

126.94 0.27 (0.21%)

0.60 0.00 (0.00%)